Diamyd Medical AB (publ) financials at a glance

+ Portfolio

The revenue of Diamyd Medical AB (publ) is reported as 0.01961 billion Kronor in the fiscal year 2023. The earnings were -1.3 Kronor per share in 2023, which was 7.14 higher than 2022. And about -0.10654 billion Kronor are reported as free cash flow in the financials of Diamyd Medical AB (publ) 2023. No dividends were paid to the shareholders of the Diamyd Medical AB (publ) stock OM:DMYD B in the financial year 2023.

kr19.61M

Revenue

kr-1.30

Earnings Per Share

0.00%

Gross Margin %

kr-,106.54M

Free Cash Flow

Revenue

19.61

Earnings Per Share

-1.30

Gross Margin %

0.00

Free Cash Flow

-,106.54

Financials

Year	Year	TTM	2023	2022	2021	2020	2019
Rev.	Revenue	N/A	kr19.61M	kr0.45M	kr0.25M	kr1.13M	kr1.64M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	-7.97%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	kr-1.48	kr-1.30	kr-1.40	kr0.90	kr0.10	kr-0.50
Div.	Dividends	N/A	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00
PR %	Payout Ratio %	0	0	0	0	0	0
Sha.	Shares	N/AM	85.78M	76.93M	71.57M	69.17M	69.17M
OCF	Operating Cash Flow	N/A	kr-95.10M	kr-93.26M	kr-,109.47M	kr16.15M	kr-39.19M
FCF	Free Cash Flow	N/A	kr-,106.54M	kr-,113.01M	kr-,113.69M	kr14.18M	kr-39.19M
FCFS	Free Cash Flow Per Share	kr-1.56	kr-1.56	kr-1.67	kr-1.63	kr0.22	kr-0.60

Diamyd Medical AB (publ) financials at a glance

Financials

Discover